Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History $0.01 0.00 (0.00%) As of 08/13/2025 02:29 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals Stock Price Performance The Virpax Pharmaceuticals (VRPX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.95%, with a year-to-date return of -99.88%. In the past month, the stock has decreased 96.95%, reflecting recent market activity. As of the latest close, Virpax Pharmaceuticals traded at $0.01 with a market cap of $14 thousand and volume of 820 shares. Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-96.95%3 Month Performance-95.45%Year-To-Date Performance-99.88%1 Year Performance-99.95% VRPX Stock Chart for Friday, August, 15, 2025 VRPX Chart by TradingView Virpax Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$0.01$0.01$0.01$0.01820 shs$14,000.0008/13/2025$0.01$0.01$0.01$0.01820 shs$14,000.0008/12/2025$0.01$0.01$0.01$0.01675 shs$14,000.0008/11/2025$0.01$0.01$0.01$0.01320 shs$14,000.0008/08/2025$0.01$0.01$0.01$0.01800 shs$14,000.0008/07/2025$0.01$0.01$0.01$0.012,525 shs$14,000.0008/06/2025$0.01$0.01$0.01$0.01165 shs$14,000.0008/05/2025$0.01$0.01$0.01$0.014,078 shs$14,000.0008/04/2025$0.01$0.01$0.01$0.012,196 shs$14,000.0008/01/2025$0.01$0.01$0.01$0.01290 shs$14,000.00 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$0.01$0.01$0.01$0.01290 shs$14,000.0007/30/2025$0.06$0.01-80.18%$0.01$0.011,465 shs$14,000.0007/29/2025$0.06$0.06$0.06$0.06594 shs$69,000.0007/28/2025$0.02$0.06+164.29%$0.06$0.06594 shs$69,000.0007/25/2025$0.02$0.02+4.48%$0.02$0.025,940 shs$26,000.0007/24/2025$0.02$0.02+0.50%$0.02$0.02658 shs$25,000.0007/23/2025$0.06$0.02-66.44%$0.02$0.012,185 shs$25,000.0007/22/2025$0.33$0.06-81.94%$0.11$0.0158,680 shs$74,000.0007/21/2025$0.40$0.33-17.50%$0.37$0.335,296 shs$410,000.0007/18/2025$0.44$0.40-9.09%$0.43$0.3911,184 shs$497,000.0007/17/2025$0.42$0.44+4.76%$0.46$0.428,903 shs$546,000.0007/16/2025$0.36$0.42+16.34%$0.42$0.3642,123 shs$522,000.0007/15/2025$0.37$0.36-2.46%$0.37$0.362,201 shs$448,000.0007/14/2025$0.35$0.37+4.67%$0.42$0.3614,648 shs$460,000.00 Related Companies NAVB Stock Price Chart SYRS Stock Price Chart SCPS Stock Price Chart EVLO Stock Price Chart CMRA Stock Price Chart GNCAQ Stock Price Chart GNCA Stock Price Chart ARDS Stock Price Chart STAB Stock Price Chart AMPE Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access